Candel Therapeutics Inc (CADL)
8.98
-0.04
(-0.44%)
USD |
NASDAQ |
May 06, 15:02
Candel Therapeutics Total Assets (Quarterly): 41.20M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 41.20M |
| September 30, 2023 | 50.06M |
| June 30, 2023 | 58.71M |
| March 31, 2023 | 67.24M |
| December 31, 2022 | 77.69M |
| September 30, 2022 | 85.01M |
| June 30, 2022 | 93.30M |
| Date | Value |
|---|---|
| March 31, 2022 | 101.56M |
| December 31, 2021 | 89.20M |
| September 30, 2021 | 95.96M |
| June 30, 2021 | 30.74M |
| March 31, 2021 | 35.09M |
| December 31, 2020 | 38.28M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
30.74M
Minimum
Jun 2021
101.56M
Maximum
Mar 2022
66.47M
Average
67.24M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
| Allurion Technologies Inc | 71.71M |
| AngioDynamics Inc | 324.84M |
| Eliem Therapeutics Inc | 110.47M |
| Macrogenics Inc | 298.42M |
| GlycoMimetics Inc | 45.32M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 28.46M |
| Shareholders Equity (Quarterly) | 12.74M |